• SENSEX 74,294.96
    -19.63 (--0.03%)
  • BANKNIFTY 56,358.70
    302.95 (+0.54%)
  • HDFC Bank
    733.50 1,020.35(%)
  • ITC
    262.20 256.25(%)
  • The Bombay Burmah
    1,531.60 2,135.00(%)
  • Rentomojo
    492.20 480.00(%)
  • Glass Wall Syst.
    304.50 304.50(%)
  • Multi Comm. Exc.
    3,232.00 1,545.65(%)
  • UltraTech Cem.
    10,670.00 10,329.00(%)
  • Adani Total Gas
    674.80 859.70(%)
  • EIH
    320.50 414.90(%)
  • Bajaj Finance
    1,036.10 1,177.60(%)
  • Lords Mark Industries
    89.68 669.70(%)
  • Meesho
    219.80 254.65(%)
  • Syrma SGS Tech.
    1,764.95 1,764.95(%)
  • Aditya Birla Cap
    404.25 430.55(%)
  • Raksan Transformers
    286.65 286.65(%)
  • Atul
    6,195.10 7,198.20(%)
  • Karamtara Engg.
    378.20 378.20(%)
  • TCS
    2,101.00 1,976.00(%)
  • Billionbrains
    195.50 227.00(%)
  • Tata Chemicals
    688.00 581.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Solara Active Pharma Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70281.0
  • ISIN : INE624Z01016
742.05 0 (0.05%)
  • As on 19 Sep 2026 (EOD)

  • Today’s Low

    730.00

  • Today’s High

    750.40

  • Open

    741.70

  • Perv Close

    741.70

  • 52W Low

    422.00

  • 52W High

    774.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    3,601.33

  • Div & Yield %

    0.00

  • Book Value(₹)

    259.51

  • Debt-Equity Ratio

    0.05

  • AGM Date

    18-Sep-2026

  • EPS

    1.05

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    3,601.33

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    48.53

  • BV (₹)

    259.50

  • Sales( ₹ in Cr.)

    1,368.98

  • NP (in Cr.)

    -1.35

  • NP Var(%)

    -25.0

  • Div%

    0.0

  • CPS (₹)

    20.30

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    3,595.27

  • 52 Week High

    774.00

  • 52 Week Low

    422.00

  • Price BSE

    741.0

  • Price NSE

    742.00

  • Market Capital( in Cr.)

    3,595.27

  • P/C Ratio

    36.60

  • P/E Ratio

    -2,663.90

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,368.98 1,283.76 1,288.92 1,443.81 1,268.34 1,616.88
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,368.98 1,283.76 1,288.92 1,443.81 1,268.34 1,616.88
Other Income 5.89 9.14 5.37 22.14 18.76 28.41
Stock Adjustments -8.25 -39.00 -39.27 -7.05 258.75 2.15
Total Income 1,366.62 1,253.90 1,255.02 1,458.90 1,545.85 1,647.44
EXPENDITURE :            
Raw Materials 676.26 587.41 765.75 781.78 912.64 726.56
Power and Fuel Cost 98.47 94.37 122.56 107.95 93.70 85.42
Employee Cost 223.80 214.75 246.57 228.05 234.20 227.63
Other Manufacturing Expenses 92.81 67.80 109.31 90.76 97.87 91.19
Selling and Administration Expenses 64.48 59.10 70.40 67.50 76.39 76.07
Miscellaneous Expenses 28.72 20.56 222.41 26.68 35.43 26.83
Employee Benefit Expenses 223.80 214.75 246.57 228.05 234.20 227.63
Less: Preoperative Expenditure 4.60 3.07 2.65 0.00 0.00 0.00
Total Expenses 1,179.94 1,040.92 1,534.35 1,302.72 1,450.23 1,233.70
Operating Profit 186.68 212.98 -279.33 156.18 95.62 413.74
Interest 94.24 114.81 105.97 90.06 75.27 84.47
Gross Profit 92.44 98.17 -385.30 66.12 20.35 329.27
Depreciation 99.68 99.25 103.03 110.90 112.01 108.31
Profit Before Tax -7.24 -1.08 -488.33 -44.78 -91.66 220.96
Current Tax 0.00 0.00 0.00 -0.11 0.00 38.64
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 78.54 -22.46 -33.10 -38.64
Reported Net Profit -7.24 -1.08 -566.87 -22.21 -58.56 220.96
Extraordinary Items -5.89 0.00 -158.84 -0.45 -4.26 1.65
Adjusted Net Profit -1.35 -1.08 -408.03 -21.76 -54.30 219.31
Adjustment below Net Profit 0.00 0.00 0.56 -1.76 2.01 -2.53
P & L Balance brought forward -296.16 -295.37 250.04 274.01 341.34 142.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -0.44 -0.29 0.00 0.00 10.78 19.74
P & L Balance carried down -302.96 -296.16 -316.27 250.04 274.01 341.34
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 30.00 0.00 70.00
Dividend Per Share(Rs) 0.00 0.00 0.00 3.00 0.00 7.00
Earnings Per Share-Unit Curr -1.63 -0.27 -157.46 -6.17 -16.27 61.50
Earnings Per Share(Adj)-Unit Curr -1.63 -0.27 -145.12 -5.69 -15.00 56.68
Book Value 282.06 272.35 260.39 417.54 424.18 443.30
Book Value(Adj)-Unit Curr 282.06 272.35 239.98 384.83 390.94 408.56

Shareholding Pattern

  • Promoter Group

    41.93%

  • Public Share Holding

    58.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 16,306,480 33.80 16,306,480 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,401,417 7.05 3,401,417 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 523,384 1.08 523,384 1
Others 0 0.00 0 0
Sub Total 20,231,281 41.93 20,231,281 19
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,354 0.00 1,354 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,308 0.00 1,308 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,557,159 11.52 5,557,159 58
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 459,011 0.95 459,011 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,343,915 2.79 1,343,915 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,362,747 15.26 7,362,747 74
2] Non Institution
Bodies Corporate 4,168,431 8.64 4,167,992 434
Clearing Members 76 0.00 76 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 585,197 1.21 583,884 1,604
Foreign Non Institution Other 723,500 1.50 723,500 2
Hindu Undivided Families 575,615 1.19 575,522 1,498
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,229,908 6.69 3,229,908 61
Individuals holding nominal share capital up to Rs. 1 lakh 9,235,547 19.14 9,213,254 66,719
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 9,094 0.02 9,094 2
Others 83,949 0.17 83,949 3
Sub Total 20,651,984 42.81 20,627,846 70,397
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,246,012 100.00 48,221,874 70,490

Company Background

Solara Active Pharma Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Solara Active Pharma Sciences Ltd
  • BSE Code : 70281.0
  • ISIN : INE624Z01016

  • Incorporation Year

    2017

  • Registered Office

    201 Devavrata Sector 17 Vashi
    Navi Mumbai, Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924

  • FAX

    91-22-27892942

  • Chairman

    RAJAGOPALAN RAMAKRISHNAN

  • Managing Director

    Sandeep Rao

  • Company Secretary

    Pooja Jaya Kumar

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Solara Active Pharma Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Solara Active 740.80 1,374.87 1,368.98 -4,630.00 0.00
Abbott India 27,273.30 7,217.19 6,929.05 35.89 43.78
Astrazeneca Phar 6,751.40 2,304.07 2,275.58 99.50 27.86
Glaxosmi. Pharma 2,851.85 3,932.76 3,790.20 45.56 58.17
Novartis India 2,057.50 393.10 354.33 51.96 15.94
Cipla 1,371.45 20,102.60 18,979.95 36.04 13.88
Bliss GVS Pharma 680.40 773.53 729.81 63.23 12.51
Amrutanjan Healt 493.65 520.13 502.55 26.44 24.16
Fermenta Biotec. 475.75 474.15 450.25 22.21 18.77
Guj. Themis Bio. 427.65 168.25 165.82 114.34 18.05
Ambalal Sarabhai 40.45 19.52 3.94 74.91 6.77